Formulation and Evaluation of Transdermal Patch of Repaglinide

Repaglinide has the half life of 1 hour, and bioavailability in the body is 56% due to first-pass metabolism. The total daily dose of Repaglinide is 16 mg (e.g., 4 mg four times daily depending on meal patterns); hence, it required frequent dosing. Transdermal patch of Repaglinide was prepared to su...

Descripción completa

Detalles Bibliográficos
Autores principales: Prajapati, Shailesh T., Patel, Charmi G., Patel, Chhagan N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263722/
https://www.ncbi.nlm.nih.gov/pubmed/22389856
http://dx.doi.org/10.5402/2011/651909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263722/
https://www.ncbi.nlm.nih.gov/pubmed/22389856
http://dx.doi.org/10.5402/2011/651909

Ejemplares similares